Literature DB >> 21200181

Beyond the target pathogen: ecological effects of the hospital formulary.

Ellie J C Goldstein1.   

Abstract

PURPOSE OF REVIEW: Antibiotic therapy has the potential for intended as well as unintended consequences due to ecological effects that extend beyond the target pathogen. This review examines some of the collateral damage and collateral benefit that may occur when using antibiotic therapy. RECENT
FINDINGS: Antibiotics excreted in the gastrointestinal tract cause alterations of the indigenous flora. Such disruptions may increase the risk of colonization and overgrowth of pathogenic bacteria, including resistant species, with the potential for serious infection for an individual patient as well as possible hospital-wide dissemination resulting in local outbreaks of infection. For example, Clostridium difficile infection (CDI), and particularly associated diarrhea and colitis, is a potentially serious and growing problem in hospitals worldwide, and is associated with disruption of gut flora through use of broad-spectrum antibiotics, especially those with antianaerobic activity. Infection control measures and improved antibiotic stewardship are key measures for CDI prevention. Another example is the risk of intestinal colonization and overgrowth with resistant bacteria, which is heightened in surgical patients requiring antimicrobial therapy for intraabdominal infections. Results from two Optimizing Intra-Abdominal Surgery with Invanz studies (OASIS-I and OASIS-II) suggested emergence of resistant Enterobacteriaceae was less likely in these patients treated with ertapenem than in those treated with ceftriaxone/metronidazole or piperacillin/tazobactam. Finally, recent studies have reported that increased use of a nonpseudomonal carbapenem such as ertapenem does not reduce the susceptibility of Pseudomonas aeruginosa to pseudomonal carbapenems, for example, imipenem or meropenem. In fact, data from one study showed increased ertapenem/decreased imipenem use was associated with improved susceptibility of P. aeruginosa to imipenem, probably due to decreased selective pressure for resistant species.
SUMMARY: Improper antibiotic use can be associated with detrimental effects related to the ecological impacts of these drugs. Improved antibiotic stewardship and appropriate infection control measures are key to minimization of the collateral damage associated with antibiotic therapy and may even have collateral benefits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21200181     DOI: 10.1097/01.qco.0000393485.17894.4c

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  18 in total

1.  The neonatal group B streptococcal epidemic: lessons learned from studying associations.

Authors:  Michael P Sherman; Michael S Cooperstock
Journal:  Neonatology       Date:  2011-10-18       Impact factor: 4.035

Review 2.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Can a collaborative subspecialty antimicrobial stewardship intervention have lasting effects?

Authors:  Kaushal B Shah; Ramzy H Rimawi; Mark A Mazer; Paul P Cook
Journal:  Infection       Date:  2017-07-19       Impact factor: 3.553

4.  Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.

Authors:  Nicholas G Brown; Lori B Horton; Wanzhi Huang; Sompong Vongpunsawad; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2011-09-06       Impact factor: 5.191

Review 5.  Antibiotics for uncomplicated diverticulitis.

Authors:  Marie-Louise Dichman; Steffen Jais Rosenstock; Daniel M Shabanzadeh
Journal:  Cochrane Database Syst Rev       Date:  2022-06-22

6.  Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit.

Authors:  H Habayeb; B Sajin; K Patel; C Grundy; A Al-Dujaili; S Van de Velde
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 3.267

7.  Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.

Authors:  Aziz Ogutlu; Ertugrul Guclu; Oguz Karabay; Aylin Calica Utku; Nazan Tuna; Mehmet Yahyaoglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-01-09       Impact factor: 3.944

Review 8.  Can we prevent antimicrobial resistance by using antimicrobials better?

Authors:  Germander Soothill; Yanmin Hu; Anthony Coates
Journal:  Pathogens       Date:  2013-06-10

9.  Perceptions and Practices of Community Pharmacists towards Antimicrobial Stewardship in the State of Selangor, Malaysia.

Authors:  Muhammad Umair Khan; Mohamed Azmi Ahmad Hassali; Akram Ahmad; Ramadan Mohamed Elkalmi; Syed Tabish Razi Zaidi; Sameer Dhingra
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

10.  The gut is the epicentre of antibiotic resistance.

Authors:  Jean Carlet
Journal:  Antimicrob Resist Infect Control       Date:  2012-11-27       Impact factor: 4.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.